ArticleJournal for immunotherapy of cancer2022

Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood.

Jennifer Wilkinson Carlisle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.